Over the past two decades, the field of microbiology has undergone a profound transformation driven by advances in genomic technologies, particularly whole-genome sequencing (WGS). Microbial genomics has emerged as a cornerstone of modern molecular epidemiology, providing unprecedented insights into the transmission dynamics of infectious diseases. By analyzing the complete genetic composition of microorganisms, researchers can identify subtle genetic variations between isolates, enabling accurate reconstruction of transmission pathways and identification of outbreak sources. The integration of genomic data with traditional epidemiological information has significantly improved the ability to monitor, detect, and control infectious disease outbreaks in both community and healthcare settings [1]. Traditional outbreak investigations relied primarily on classical epidemiological tools such as case interviews, contact tracing, and case-control studies, along with molecular typing techniques such as pulsed-field gel electrophoresis or multilocus sequence typing. Although these methods have been valuable for decades, they often lack the resolution required to distinguish between closely related microbial strains. Whole-genome sequencing overcomes this limitation by examining the entire genetic content of pathogens, allowing the detection of small genetic differences such as single nucleotide polymorphisms (SNPs). These minute variations act as molecular signatures that can reveal evolutionary relationships between isolates and determine whether infections originate from a common source or represent independent events [2]. Evidence from scientific literature indicates that microbial genomics provides substantially higher resolution compared with conventional epidemiological typing methods. A scoping review analyzing 275 studies reported that 164 of them used whole-genome sequencing directly for outbreak investigations. The applications included identifying infection sources, clarifying transmission pathways, detecting emerging strains, and monitoring antimicrobial resistance patterns [3]. Such genomic analyses allow researchers to uncover previously unrecognized links between cases and to detect outbreaks earlier than traditional surveillance methods. The application of microbial genomics has been particularly valuable in investigating healthcare-associated infections, which remain a major challenge for healthcare systems worldwide. In one study involving genomic surveillance of Pseudomonas aeruginosa infections in a hospital setting, researchers identified a cluster of six genetically related cases occurring over a seven-month period. Genomic analysis revealed that the infections were linked to a contaminated gastroscope used in multiple patients, demonstrating how genomic epidemiology can pinpoint transmission routes that would otherwise remain undetected [4]. Early identification of such sources can enable rapid infection control measures and potentially prevent additional cases. Microbial genomics also allows reconstruction of transmission networks with remarkable precision. By comparing genomic sequences from different patients, researchers can construct phylogenetic trees that illustrate how pathogens spread within a population. In an investigation of a multidrug-resistant Acinetobacter baumannii outbreak in a hospital, whole-genome sequencing analysis revealed that 74 out of 102 isolates belonged to a single outbreak cluster based on fewer than eight single-nucleotide differences between strains [2]. Such high-resolution genomic data enable investigators to distinguish between hospital-acquired infections and independent introductions from external sources. Another major contribution of microbial genomics lies in its capacity to monitor pathogen evolution at local, national, and global levels. Large genomic databases containing thousands of microbial genome sequences allow scientists to compare isolates from different regions and track the emergence of epidemic strains. Initiatives such as the “100K Pathogen Genome Project” aim to sequence the genomes of one hundred thousand pathogenic microorganisms to create comprehensive reference databases that facilitate rapid identification of pathogens and their sources during outbreaks [5]. The significance of genomic epidemiology became particularly evident during the COVID-19 pandemic. Sequencing of SARS-CoV-2 genomes enabled researchers to track the emergence and global spread of viral variants in real time. By combining genomic sequencing with traditional contact tracing, investigators were able to identify transmission events among patients and healthcare workers, differentiate hospital-acquired infections from community introductions, and monitor the emergence of variants of concern with enhanced transmissibility [6]. These insights played a crucial role in guiding public health interventions and informing vaccination and containment strategies. In addition to tracing outbreaks, microbial genomics provides valuable insights into the biological characteristics of pathogens, including virulence factors and antimicrobial resistance genes. Whole-genome sequencing allows simultaneous identification of the resistome and virulome of a pathogen, offering a comprehensive understanding of its pathogenic potential. This capability is particularly important in the context of the global rise in antimicrobial resistance, which poses a significant threat to public health and complicates the treatment of infectious diseases. Despite its transformative potential, the widespread implementation of microbial genomics in routine public health practice still faces several challenges. These include the need for advanced sequencing infrastructure, bioinformatics expertise for data analysis, and effective integration of genomic data with epidemiological and clinical information systems. Moreover, the interpretation of genomic results requires careful consideration of evolutionary rates and sampling strategies to avoid misleading conclusions. Nevertheless, the continuous decline in sequencing costs and the rapid development of bioinformatics tools are expected to facilitate broader adoption of genomic surveillance in the near future [3]. In conclusion, microbial genomics has become a fundamental component of modern infectious disease epidemiology. By providing high-resolution insights into pathogen evolution and transmission, genomic technologies enable more accurate outbreak detection, source attribution, and infection control strategies. The integration of genomic data with traditional epidemiological approaches represents a powerful framework for improving global preparedness and response to emerging infectious diseases. As sequencing technologies continue to advance, microbial genomics will play an increasingly critical role in safeguarding public health and combating infectious disease outbreaks worldwide.